These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 10206830

  • 1. Pravastatin and coronary heart disease.
    Meyer FP.
    N Engl J Med; 1999 Apr 08; 340(14):1115-6; author reply 1116-7. PubMed ID: 10206830
    [No Abstract] [Full Text] [Related]

  • 2. Effect of pravastatin on cardiovascular events and mortality in 1516 women with coronary heart disease: results from the Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) study.
    Hague W, Forder P, Simes J, Hunt D, Tonkin A, LIPID Investigators.
    Am Heart J; 2003 Apr 08; 145(4):643-51. PubMed ID: 12679760
    [Abstract] [Full Text] [Related]

  • 3. Pravastatin and coronary heart disease.
    Bloom JM.
    N Engl J Med; 1999 Apr 08; 340(14):1116-7. PubMed ID: 10206831
    [No Abstract] [Full Text] [Related]

  • 4. [For coronary disease patients is certain: the lower the LDL the better].
    MMW Fortschr Med; 2006 Jun 15; 148(24):6. PubMed ID: 16850797
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Statins and cardiovascular disease prevention: use and prospective].
    Moulin P.
    Nephrologie; 2000 Jun 15; 21(7):379-80. PubMed ID: 11200617
    [No Abstract] [Full Text] [Related]

  • 8. Overlap analysis of the West of Scotland coronary prevention study (WOSCOPS).
    Lim PO, Yee KM.
    Circulation; 1999 Aug 10; 100(6):686. PubMed ID: 10441109
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Long-term follow-up of the West of Scotland Coronary Prevention Study.
    DeFilippis AP, Bansal S, Blumenthal RS.
    N Engl J Med; 2008 Jan 10; 358(2):194; author reply 194-5. PubMed ID: 18193527
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Long-term follow-up of the West of Scotland Coronary Prevention Study.
    McEvoy JW, Margey R, Blake GJ.
    N Engl J Med; 2008 Jan 10; 358(2):193; author reply 194-5. PubMed ID: 18184967
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [HMG-CoA reductase inhibitors for prevention and treatment of coronary heart disease. Effective reduction of cardiac events and mortality].
    Windler E.
    Fortschr Med; 1996 Mar 20; 114(8):89-90. PubMed ID: 8647573
    [No Abstract] [Full Text] [Related]

  • 19. Lipid-lowering therapy and risk of coronary events.
    Mascitelli L, Pezzetta F.
    JAMA; 1996 Mar 20; 289(16):2071; author reply 2071-2. PubMed ID: 12709464
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.